BRD2 and neoplasm: In addition, the advantage of our delta radiomics model is, as mentioned, its dynamic nature, allowing to measure changes occurring in the tumor during NAT with the potential to predict/assess the impact of a specific treatment in real time (i.e., predictive biomarker) and gain biological insight in tumor biology.